Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New antiparasitic agents in development at Bayer

Dec. 1, 1998

Alkermes, Schering-Plough agree to terminate collaboration

Nov. 30, 1998

Shionogi claims new agents for influenza

Nov. 30, 1998

Antimicrobial and antitumor activity of xenomin compounds described

Nov. 30, 1998

Viral and nonviral serine protease inhibitors developed at Emory University

Nov. 27, 1998

Design, synthesis and antiviral activity of A-5021 discussed this week in Kyoto

Nov. 26, 1998

Preliminary results announced for pleconaril pediatric study; other trials in progress

Nov. 26, 1998

Herpesvirus protease inhibitors developed at SmithKline Beecham

Nov. 25, 1998

Pentose receives SBIR grant to support Inactine development

Nov. 25, 1998

Bayer claims broad-spectrum oxazolidinones

Nov. 23, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...